LYSMD2 antibody
Principal name
LYSMD2 antibody
Alternative names for LYSMD2 antibody
LysM and putative peptidoglycan-binding domain-containing protein 2
Gene ID
256586 (LYSMD2)
Ncbi ID
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of LYSMD2 antibody
Transient overexpression lysate of LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 1
LYSMD2 MaxPab polyclonal antibody. Western Blot analysis of LYSMD2 expression in rat brain.
Western Blot analysis of LYSMD2 expression in transfected 293T cell line by LYSMD2 MaxPab polyclonal antibody.Lane 1: LYSMD2 transfected lysate(23.65 KDa).Lane 2: Non-transfected lysate.
Human HepG2; WB Suggested Anti-LYSMD2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: HepG2 cell lysate; LYSMD2 antibody - middle region (ARP55592_P050) in Human HepG2 cells using Western Blot
WB Suggested Anti-LYSMD2 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:312500; Positive Control: HepG2 cell lysate
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA330943 | LYSMD2 antibody |
||||||
| Rabbit polyclonal Anti-LYSMD2 Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, GP, Hu, Ms, Por, Rb, Ze | WB |
50 µg /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY407085 | LYSMD2 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC206742L2V | Lenti ORF particles, LYSMD2 (mGFP-tagged) - Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€907.00
|
|
| OriGene Technologies, Inc. | ||
| RC226912L2V | Lenti ORF particles, LYSMD2 (mGFP-tagged)-Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€907.00
|
|
| OriGene Technologies, Inc. | ||
| RC206742L1V | Lenti ORF particles, LYSMD2 (Myc-DDK tagged) - Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€804.00
|
|
| OriGene Technologies, Inc. | ||
| RC226912L1V | Lenti ORF particles, LYSMD2 (Myc-DDK-tagged)-Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€804.00
|
|
| OriGene Technologies, Inc. | ||
